Current therapy is effective at inducing remission in adult patients with acute myeloid leukemia, but most patients later succumb after a relapse. That relapse has been thought to be caused by rare and dormant cancer stem cells that escape chemotherapy.
At McMaster's Stem Cell and Cancer Research Institute, researchers are working with human stem cells to improve health-care options for patients who currently have few or none.
Researchers from the McMaster Stem Cell and Cancer Research Institute found that boosting fat cells located in the bone morrow suppressed cancerous leukemia cells but induced the regeneration of healthy blood cells at the same time.
McMaster logo
McMaster logo
